论文部分内容阅读
【据《Hepatology》2015年6月报道】题:抗病毒治疗对乙型肝炎肝硬化失代偿期患者疾病进展的长期影响(作者Jang JW等)病毒抑制对乙型肝炎肝硬化失代偿期患者长期预后的影响目前还没有被研究。为了研究抗病毒治疗对乙型肝炎肝硬化失代偿期患者的疾病进展的长期影响,韩国加图立大学的Jang等进行了一项多中心、前瞻性、起始队列研究。共有707例首次发生肝硬化并发症的患者被纳入研究中,包括284例未治疗者,423例抗病毒治疗
[According to “Hepatology” June 2015 report] Title: Long-term effects of antiviral therapy on disease progression in patients with decompensated hepatitis B (by Jang JW, et al.) Viral suppression effects on decompensated hepatitis B cirrhosis The long-term prognosis of patients has not been studied. To investigate the long-term impact of antiretroviral therapy on disease progression in patients with hepatitis B cirrhosis and decompensation, a multicenter, prospective, cohort cohort study was conducted by Jang et al. At Cato, Korea. A total of 707 patients with first-time cirrhosis complication were included in the study, including 284 untreated and 423 antiviral